Noah D. Kauff, MD, FACOG

Gynecologist and Geneticist

Director, Ovarian Cancer Screening and Prevention, Gynecology Service, Department of Surgery

Conditions Treated:

Noah D. Kauff, MD, FACOG -- Director, Ovarian Cancer Screening and Prevention, Gynecology Service, Department of Surgery

About Me

I am a gynecologist and geneticist who specializes in the care of patients who may have an inherited predisposition to cancer. I evaluate and treat all hereditary cancer syndromes, including those that cause an increased risk of breast, ovarian, colon, uterine, thyroid, and other cancers. My clinical areas of expertise include cancer risk counseling, screening for and prevention of inherited cancers, and providing gynecologic care to cancer patients.

Read more

My research interests include: The effect of genetic counseling on the evaluation and treatment of women with an inherited predisposition to cancer; the effect of risk-reducing surgery for the prevention of breast and ovarian cancer in women with inherited predisposition to these cancers; and the identification of both genetic and environmental markers that may allow risk-reduction strategies to be tailored to individual patients at increased risk for cancer.

  • Clinical Expertise: Genetic Predisposition to Cancer; Cancer Risk Counseling; Gynecologic Care of the Cancer Patient
  • Languages Spoken: English
  • Education: MD, University of Pennsylvania School of Medicine
  • Residencies: New York Medical College
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Obstetrics and Gynecology

My Research

View my lab

See Noah D. Kauff’s laboratory
research at Memorial Sloan Kettering.

Publications

Selected Book Chapters
“Risk-reducing salpingo-oophorectomy in patients with BRCA1 and BRCA2 mutations.” Kauff ND, Barakat RR, Offit K. In: Progress in Oncology. Devita VT Jr., Hellman S, Rosenberg SA, eds. Sudbury, MA: Jones and Bartlett; 2003.

“Beyond BRCA1 and BRCA2 breast cancer genetics.” Isaacs C, Kauff ND, Domchek SM. In: American Society of Clinical Oncology 2006 Educational Book. Perry MC, ed. Alexandria, VA: American Society of Clinical Oncology; 2006: 57-62.

“Management of BRCA-negative hereditary breast cancer families.” Kauff ND. In: Hereditary Breast Cancer. Isaacs C, Rebbeck TR, eds. Oxford: Taylor and Francis; 2007.

“Cancers of the ovaries, peritoneum, and fallopian tube.” Chi DS, Kauff ND. In: Precis: Oncology. 3rd ed. American College of Obstetricians and Gynecologists Women’s Health Care Physicians. Washington: American College of Obstetricians and Gynecologists; 2008.

Read more

“Risk-reducing salpingo-oophorectomy for the prevention of inherited breast and ovarian cancer.” Lewin SN, Kauff ND. In: Hereditary Gynecologic Cancer: Risk, Prevention and Management. Lu KH, ed. New York: Informa Healthcare; 2008.

“Management of BRCA mutation-negative patients.” Gallagher DJ, Kauff ND, eds. In: Hereditary Gynecologic Cancer: Risk, Prevention and Management. Lu KH, ed. New York: Informa Healthcare; 2008.

“Genetics of hereditary gynecologic cancers.” Levine DA, Kauff ND, Boyd J. In: Atlas of Cancer. 2nd ed. Markman M, ed. Philadelphia: Current Medicine; 2008.

“Cancer of the ovary.” Alektiar KM, Chi DS, Kauff ND, Fuks ZY. In: Leibel and Phillips Textbook of Radiation Oncology. Hoppe R, Phillips TL, Roach M, eds. Philadelphia: Saunders; 2010.


Visit PubMed for a full listing of Noah D. Kauff’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more